Blackstone to invest up to $250 million in British biotech company Autolus
November 07, 2021 at 22:57 PM EST
Blackstone Inc. is investing as much as $250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of leukemia, the companies said.
